1. Shifting Coronavirus Disease 2019 Testing Policy and Research to Include the Full Translation Pipeline
- Author
-
M. Margaret Dolcini, E. Roberto Orellana, Joseph A. Catania, Jeffrey N. Martin, and Jeffrey Henne
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Population ,translation ,dissemination ,03 medical and health sciences ,Rapid screening test ,0302 clinical medicine ,Medicine ,030212 general & internal medicine ,education ,Rapid testing ,education.field_of_study ,030505 public health ,SARS-CoV-2 ,business.industry ,Pipeline (software) ,reach ,testing ,AcademicSubjects/MED00290 ,Infectious Diseases ,Risk analysis (engineering) ,Oncology ,Brief Reports ,0305 other medical science ,business ,Coronavirus Infections - Abstract
The current severe acute respiratory syndrome coronavirus 2 testing policy and practice limits testing as a prevention tool. Radical shifts are required to increase the scale of rapid testing strategies and improve dissemination and implementation of venue-based and self-testing approaches. Attention to the full translation pipeline is required to reach high-risk segments of the population., We propose a broad translation perspective be applied to COVID-19 testing development with the goals of improving not only scalability, but also test dissemination, implementation, and reach.
- Published
- 2021
- Full Text
- View/download PDF